The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Fully equipped labs with 75-member team set-up and made operational in <100 days
The combination will support clients in getting their end-to-end discovery and development programs delivered.
The new sterile filling line meets cGMP aseptic filling regulatory requirements
Revenue from operations up 26% to Rs. 768 crores
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform
Subscribe To Our Newsletter & Stay Updated
